BMJ Open (Feb 2022)

Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study

  • ,
  • Marjon H Cnossen,
  • Frank W G Leebeek,
  • Ron A A Mathôt,
  • M Coppens,
  • MJHA Kruip,
  • S Polinder,
  • K Fischer,
  • R Liesner,
  • K Fijnvandraat,
  • Laura H Bukkems,
  • PW Collins,
  • P Chowdary,
  • K Meijer,
  • A Janssen,
  • MH Cnossen,
  • Jessica M Heijdra,
  • Wala Al Arashi,
  • Nico C B de Jager,
  • Michael E Cloesmeijer,
  • Christian M Zwaan,
  • FWG Leebeek,
  • RAA Mathôt,
  • RYJ Tamminga,
  • BAP Laros-van Gorkom,
  • P Brons,
  • SEM Schols,
  • FJM van der Meer,
  • HCJ Eikenboom,
  • REG Schutgens,
  • F Heubel-Moenen,
  • L Nieuwenhuizen,
  • P Ypma,
  • MHE Driessens,
  • CM Zwaan,
  • I van Vliet,
  • D Keeling,
  • J Lock,
  • HCAM Hazendonk,
  • I van Moort,
  • T Preijers,
  • JM Heijdra,
  • NCB de Jager,
  • MCHJ Goedhart,
  • LH Bukkems,
  • W Al Arashi,
  • ME Cloesmeijer

DOI
https://doi.org/10.1136/bmjopen-2021-049493
Journal volume & issue
Vol. 12, no. 2

Abstract

Read online

No abstracts available.